-
Endo International Drops Ahead Of '60 Minutes' Opioid Segment
Friday, December 14, 2018 - 6:01pm | 455Read More...Endo International PLC (NASDAQ: ENDP) stock dropped 8.53 percent Friday after “60 Minutes” announced it will be featuring attorney general and Ohio governor-elect Mike DeWine on Sunday’s episode. What Happened? “60 Minutes,” which has been known to move markets...
-
AcelRx Shares React Positively To FDA Committee Briefing On Painkiller Candidate Dsuvia
Wednesday, October 10, 2018 - 12:32pm | 572Read More...A day after Trevena Inc (NASDAQ: TRVN) shares suffered a setback in reaction to a FDA committe's briefing document, another stock is trading higher following the release of a briefing document pertaining to its adcom review. What Happened The briefing document released by FDA's...
-
Trevena Shares Plunge As FDA Briefing Document Reveals Pain Drug Concerns
Tuesday, October 9, 2018 - 12:14pm | 354Read More...Trevena Inc (NASDAQ: TRVN) has a key catalyst Oct. 11, when the FDA's Anesthetic and Analgesic Drug Products Advisory Committee is scheduled to announce its verdict on the safety, efficacy and benefit considerations for the company's pain medication candidate Oliceridine. Ahead of the D-...
-
Analyst: Opioid Legislation Likely Stalled In Senate Until After November Elections
Saturday, July 14, 2018 - 1:54pm | 461Read More...The opioid epidemic is one of the most devastating trends in American households, with CDC data showing that 66 percent of the country's overdose deaths in 2016 were attributed to opioids. Unfortunately, Height Capital Markets analyst Andrea Harris said there’s not much hope...
-
Recro Pharma CEO Talks Non-Opioid Pain Management Opportunity, CDMO Business
Thursday, April 5, 2018 - 9:28am | 804Read More...President Donald Trump in March said he was considering suing drug companies fueling the opioid crisis — and Congress will allocate $6 billion in new funding over the next two years to advance the fight. The strategy, coupled with other policies, could bode well for Recro Pharma Inc (...
-
Imprimis Spikes On New Composition Patent For Non-Opioid Sedative
Tuesday, March 27, 2018 - 8:26am | 427Read More...Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) announced Tuesday its non-opioid, non-IV sedation formulation, MKO Melt, secured a patent for anesthesiological applications. The product, which has been dispensed more than 70,000 times since debuting in 2015, is expected to see a market-share swell from...
-
A Look At Opiant Pharmaceuticals, The Stock That Skyrocketed On Trump's Opioid Declaration
Thursday, October 26, 2017 - 4:43pm | 255Read More...Opiant Pharmaceuticals Inc (NASDAQ: OPNT) spiked 46 percent Thursday when President Donald Trump declared a crackdown on opioid abuse. “We’re going to be spending lots of money on coming up with a non-addictive solutions,” Trump said during a press conference. The company develops...
-
22 Stocks To Watch After President Trump Declares Opioid Epidemic A National Health Emergency
Thursday, October 26, 2017 - 3:24pm | 683Read More...President Donald Trump catalyzed a selloff in opioid-exposed stocks Thursday as he declared the national epidemic a public health emergency and renewed the government’s crackdown on fentanyl. “I will be pushing the concept of non addictive painkillers very, very hard,” Trump said...
-
John Kapoor, Founder Of Insys, Indicted On Charges Of Bribing Doctors To Overprescribe Opioids
Thursday, October 26, 2017 - 12:22pm | 615Read More...On the same day President Donald Trump was expected to declare the national opioid epidemic a public health emergency, a Boston Federal Court charged John Kapoor, former CEO and chairman of the opioid producing Insys Therapeutics Inc (NASDAQ: INSY), along with six other executives with a...
-
7 Stocks To Watch Ahead Of The 60 Minutes DEA-Opioid Exposé
Friday, October 13, 2017 - 10:45am | 421Read More...Drug distributors were in freefall Friday when CBS Corporation (NYSE: CBS) teased an expository “60 Minutes” episode linking these distributors to failures in the opioid crackdown. The Oct. 15 segment will highlight a joint investigation with The Washington Post revealing hindrances to...
-
Collegium Rallies On 'Value-Based Contract' With Cigna; Here's What It Means
Thursday, October 5, 2017 - 12:08pm | 406Read More...Collegium Pharmaceuticals Inc (NASDAQ: COLL) shares jumped more than 13 percent on Thursday after health insurance giant CIGNA Corporation (NYSE: CI) announced it will be discontinuing coverage of Purdue Pharma’s popular opioid painkiller OxyContin. Citing safety concerns about opioid abuse...
-
Born On The Battlefield: AcelRx Awaits FDA Ruling On Device That Delivers Potent Opioid To Wounded Soldiers
Wednesday, August 30, 2017 - 12:07pm | 999Read More...It isn't easy being a small pharmaceutical company banking on FDA approval of a painkiller product in a nation gripped by an opioid epidemic. Consider AcelRx Pharmaceuticals Inc (NASDAQ: ACRX), which has developed a fast, under-the-tongue delivery system for the opioid called sufentanil. It...
-
Petmed Drug Removed From Google Ads After Accusations Of Fueling Opioid Crisis
Thursday, August 24, 2017 - 12:33pm | 465Read More...Following allegations that Petmed Express Inc (NASDAQ: PETS) was conspiring to capitalize on the opioid epidemic, ads for the company’s Tramadol, a synthetic opiate used by both pets and cancer patients, were removed from Alphabet Inc (NASDAQ: GOOGL)’s Google searches Thursday. The ads...
-
Petmed Accused Of Marketing Animal Painkillers To Human Drug Users
Wednesday, August 23, 2017 - 1:56pm | 432Read More...Veterinary medical distributor Petmed Express Inc (NASDAQ: PETS) was accused Wednesday of conspiring to exploit the U.S. opioid epidemic in its sale of drugs like Tramadol, a synthetic opiate used by both pets and human cancer patients. Research firm Aurelius Value attributed PetMed’s sudden...
-
No Pain, No Gain: How The American Military Wants Big Pharma To Cure The Opioid Crisis
Sunday, August 20, 2017 - 10:23am | 644Read More...U.S. Army Spc. Brian Wilhelm was stationed in the Iraqi town of Balad when a rocket-propelled grenade blew up his leg. The pain was as bad as the actual injury that would eventually claim the demolished limb. Wilhelm was rushed to a MASH unit on the front. An Army colonel and anesthesiologist named...
















